ICB/FW/EPSS6/MOH-GF/Malaria/PH/14/23
October 3, 2023
Tender Code: ICB/FW/EPSS6/MOH-GF/Malaria/PH/14/23
Award Status: Partial Winners List
Award Date: 10/03/2023
Tender Award: Download
Unsuccessful Bidders:
Technical Evaluation Result:
|
|
Company Name: | Document No: OF/TM/ HO-14 | ||||||||||||
| የኢትዮጵያ መድሃኒት አቅራቢ አገልግሎት | ||||||||||||||
| Ethiopian Pharmaceuticals Supply Service (EPSS) | ||||||||||||||
| Title: | Effective date : 21/01/2022 | |||||||||||||
| Partial Official winner list | ||||||||||||||
| Official winner list of tender No : ICB/FW/EPSS6/MOH-GF/Malaria/PH/14/23 | ||||||||||||||
| Ser NO | Description | Unit | Quantity | Number of bidders to be awarded | Winner | Currency | Unit FOB price | allocated volume | Payment Term | port of shipment | Delivery Time | Remark | ||
| Supplier | Country | |||||||||||||
| 1 | Artemether + Lumefanthrine – 20mg + 120mg (6×2) – Tablet (Dispersible) | 30 | 67,193 | 3 | Ajanta Pharma Limited | India | USD | 11.10 | 40,316 | L/C | Mumbai | Within 60- 90 days from L/C opening date | Winner | |
| Second winner | Pended | The second and third winners were pended | ||||||||||||
| Third winner | ||||||||||||||
| 2 | Artemether + Lumefanthrine – 20mg+120mg (6×4) – Tablet | 30 | 426,430 | 3 | Ajanta Pharma Limited | India | USD | 15.80 | 255,858 | L/C | Mumbai | Within 60- 90 days from L/C opening date | Winner | |
| Macleods Pharmaceuticals Ltd. | India | USD | 16.25 | 106,608 | L/C | |||||||||
| Strides Pharma Global PTE LTD | India | USD | 17.70 | 63,965 | L/C at sight | Bangalore for air and chennai for sea | With 60 days after L/C opening date | Third least price | ||||||
| 3 | Primaquine Phosphate – 7.5mg base – Tablet | 10×10 | 1,224,513 | Retendered | ||||||||||
| እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Reasons for Rejection OF/TM/HO-16, 1, 21/01/2022 | |||||||||||||
| Make sure that this is the correct issue before use | ||||||||||||||
|
|
Company Name: | Document No: OF/TM/ HO-17 | ||||||||||||
| የኢትዮጵያ መድሃኒት አቅራቢ አገልግሎት | ||||||||||||||
| Ethiopian Pharmaceuticals Supply Services | ||||||||||||||
| Title: | Effective date : 21/01/2022 | |||||||||||||
| Reasons for Rejection | Rev. No.: 1 | Page 1 of 1 | ||||||||||||
| Tender no: ICB/FW/EPSS6/MOH-GF/Malaria/PH/14/23 | ||||||||||||||
| 1 | Artemether + Lumefanthrine – 20mg + 120mg (6×2) – Tablet (Dispersible) | Strides Pharma Global PTE LTD | Pended | |||||||||||
| Medicamen Biotech Ltd | ||||||||||||||
| Cipla Limited | ||||||||||||||
| Macleods Pharmaceuticals Ltd. | ||||||||||||||
| IPCA Laboratories Limited | ||||||||||||||
| Artemether + Lumefanthrine – 20mg+120mg (6×4) – Tablet | IPCA Laboratories Limited | Unsuccessful | Submitted two alternative bid or optional quotations with different prices | |||||||||||
| 2 | Cipla Limited | Unsuccessful | Price incompetence | |||||||||||
| Medicamen Biotech Ltd | Unsuccessful | The Supplier/Manufacturer was not listed on latest GF prequalification list | In GF Quality Assurance list ( Version 116 – 30-Jun-2023) | |||||||||||
| 3 | Primaquine Phosphate – 7.5mg base – Tablet | No qualifed bidders | ||||||||||||
| እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Reasons for Rejection OF/TM/HO-17, 1, 21/01/2022 | |||||||||||||
| Make sure that this is the correct issue before use | ||||||||||||||